サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683653

顔用注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Facial Injectables Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 140 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
顔用注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 140 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顔用注射剤の世界市場規模は、2024年の203億2,000万米ドルから2033年には390億6,000万米ドルに成長し、2026～2033年の予測期間中に7.53％の堅調な年間平均成長率（CAGR）を示すと予測されています。

顔用注射剤市場は、顔の外観を向上させ、老化の兆候に対処する非外科的美容施術に対する需要の増加に牽引され、大きな成長を遂げています。美に対する社会の認識が進化し、美容整形を取り巻く偏見が薄れるにつれて、若々しく若返った外見を実現するために低侵襲な選択肢を求める個人が増えています。ソーシャルメディアとインフルエンサー文化の台頭が、この動向に拍車をかけています。ボツリヌス毒素や皮膚フィラーを含む多様な製品が利用可能であるため、顔用注入物市場は競争が激化しており、メーカー各社は製品の革新と差別化を図っています。

製剤と送達方法における技術の進歩もまた、顔用注射剤市場の将来を形成しています。より長持ちし、より自然に見える製品の開発は、患者の満足度を高め、リピート施術を促進しています。さらに、注射剤を他の美容治療と併用する併用療法の導入が人気を集めており、施術者は個々のニーズに合わせた包括的なソリューションを提供できるようになっています。市場が成熟するにつれ、安全性と有効性が最重要視されるようになり、規制当局のモニタリングが強化され、製品の主張を裏付ける臨床エビデンスの必要性が高まります。

さらに、個人に合わせた美容の重要性に対する意識の高まりが、カスタマイズ型注射ソリューションの需要を促進すると予想されます。開業医がますます患者中心のアプローチを採用するようになるにつれて、個々の顔の解剖学的構造と審美的目標に基づいて治療を調整する能力が、市場における重要な差別化要因となると考えられます。顔用注入剤市場は、単に美しさを高めるだけでなく、技術、パーソナライゼーション、消費者の関与が絡み合うダイナミックなセクターであり、美的向上を求める消費者の進化するニーズに応える革新的なソリューションへの道を開くものです。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために、細心の注意を払って作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 顔用注射剤産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 顔用注射剤の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • ボツリヌス毒素
  • ヒアルロン酸
  • コラーゲン
  • ポリ乳酸
  • カルシウムハイドロキシアパタイト
  • その他

第6章 顔用注入剤の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 美容
  • 治療

第7章 顔用注射剤の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 皮膚科クリニック
  • 病院
  • スパと美容クリニック
  • その他

第8章 顔用注射剤の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 顔用注射剤企業の競合情勢

  • 顔用注入剤市場の競合
  • 提携・協力・契約
  • 合併と買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Allergan Plc
  • Galderma S.A.
  • Merz Pharmaceuticals GmbH
  • Ipsen Pharma
  • Sinclair Pharma Plc
  • Revance Therapeutics Inc.
  • Medytox Inc.
  • HUGEL Inc.
  • Anika Therapeutics Inc.
  • Teoxane Laboratories
  • Prollenium Medical Technologies Inc.
  • Suneva Medical Inc.
  • Bloomage BioTechnology Corporation Limited
  • SciVision BIoTech Inc.
  • Daewoong Pharmaceutical Co. Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Botulinum Toxin Market Sales By Geography (USD MN)
  • Hyaluronic Acid Market Sales By Geography (USD MN)
  • Collagen Market Sales By Geography (USD MN)
  • Poly-L-Lactic Acid Market Sales By Geography (USD MN)
  • Calcium Hydroxylapatite Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Aesthetic Market Sales By Geography (USD MN)
  • Therapeutic Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Dermatology Clinics Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Spas And Beauty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Facial Injectables Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Facial Injectables Report
  • Market Research Process
  • Market Research Methodology
  • Global Facial Injectables Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Botulinum Toxin Market Sales By Geography (USD MN)
  • Hyaluronic Acid Market Sales By Geography (USD MN)
  • Collagen Market Sales By Geography (USD MN)
  • Poly-L-Lactic Acid Market Sales By Geography (USD MN)
  • Calcium Hydroxylapatite Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Aesthetic Market Sales By Geography (USD MN)
  • Therapeutic Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Dermatology Clinics Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Spas And Beauty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112985

Global Facial Injectables Market size is anticipated to grow from USD 20.32 Billion in 2024 to USD 39.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period of 2026 to 2033.

The facial injectables market is experiencing significant growth, driven by the increasing demand for non-surgical aesthetic procedures that enhance facial appearance and address signs of aging. As societal perceptions of beauty evolve and the stigma surrounding cosmetic procedures diminishes, more individuals are seeking minimally invasive options to achieve youthful and rejuvenated looks. The rise of social media and influencer culture has further fueled this trend, as individuals aspire to achieve the flawless appearances often showcased online. With a diverse range of products available, including botulinum toxin and dermal fillers, the facial injectables market is becoming increasingly competitive, prompting manufacturers to innovate and differentiate their offerings.

Technological advancements in formulation and delivery methods are also shaping the future of the facial injectables market. The development of longer-lasting and more natural-looking products is enhancing patient satisfaction and driving repeat procedures. Additionally, the introduction of combination therapies, where injectables are used alongside other aesthetic treatments, is gaining popularity, allowing practitioners to offer comprehensive solutions tailored to individual needs. As the market matures, the emphasis on safety and efficacy will become paramount, leading to increased regulatory scrutiny and the need for clinical evidence to support product claims.

Furthermore, the growing awareness of the importance of personalized aesthetics is expected to drive the demand for customized injectable solutions. As practitioners increasingly adopt a patient-centric approach, the ability to tailor treatments based on individual facial anatomy and aesthetic goals will become a key differentiator in the market. The facial injectables market is not merely about enhancing beauty; it represents a dynamic sector that intertwines technology, personalization, and consumer engagement, paving the way for innovative solutions that cater to the evolving needs of consumers seeking aesthetic enhancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Botulinum Toxin
  • Hyaluronic Acid
  • Collagen
  • Poly-L-Lactic Acid
  • Calcium Hydroxylapatite
  • Others

By Application

  • Aesthetic
  • Therapeutic

By End-User

  • Dermatology Clinics
  • Hospitals
  • Spas And Beauty Clinics
  • Others
  • COMPANIES PROFILED
  • Allergan plc
  • Galderma S.A.
  • Merz Pharmaceuticals GmbH
  • Ipsen Pharma
  • Sinclair Pharma plc
  • Revance Therapeutics Inc.
  • Medytox Inc.
  • HUGEL Inc.
  • Anika Therapeutics Inc.
  • Teoxane Laboratories
  • Prollenium Medical Technologies Inc.
  • Suneva Medical Inc.
  • Bloomage BioTechnology Corporation Limited
  • SciVision Biotech Inc.
  • Daewoong Pharmaceutical Co. Ltd.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FACIAL INJECTABLES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Botulinum Toxin Historic and Forecast Sales By Regions
  • 5.4. Hyaluronic Acid Historic and Forecast Sales By Regions
  • 5.5. Collagen Historic and Forecast Sales By Regions
  • 5.6. Poly-L-Lactic Acid Historic and Forecast Sales By Regions
  • 5.7. Calcium Hydroxylapatite Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Aesthetic Historic and Forecast Sales By Regions
  • 6.4. Therapeutic Historic and Forecast Sales By Regions

7. GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Dermatology Clinics Historic and Forecast Sales By Regions
  • 7.4. Hospitals Historic and Forecast Sales By Regions
  • 7.5. Spas And Beauty Clinics Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FACIAL INJECTABLES COMPANIES

  • 9.1. Facial Injectables Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF FACIAL INJECTABLES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Allergan Plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Galderma S.A.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merz Pharmaceuticals GmbH
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Ipsen Pharma
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Sinclair Pharma Plc
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Revance Therapeutics Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Medytox Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. HUGEL Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Anika Therapeutics Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Teoxane Laboratories
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Prollenium Medical Technologies Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Suneva Medical Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Bloomage BioTechnology Corporation Limited
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. SciVision Biotech Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Daewoong Pharmaceutical Co. Ltd
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies